Similarly, a diffusely invading IDH wild-type astrocytic neoplasm without necrosis or microvascular proliferation but showing either EGFR amplification, TERT promoter mutation or a combined loss of chromosome 10 plus gain of chromosome 7 will be called a “GBM” despite the lack of histological hallmarks. This evidence concerns the gene EGFR and glioblastoma.